Development of a Rapid and Accurate Diagnostic Assay for Tuberculosis

Development of a Rapid and Accurate Diagnostic Assay for Tuberculosis by Using New Sample Preparation and Detection Technique

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03423550

Enrollment

300

Registered

2018-02-06

Start date

2018-01-16

Completion date

2021-12-30

Last updated

2021-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis

Brief summary

This study evaluates new technique for diagnosis of tuberculosis. Among patients who are suspected with tuberculosis, participants will be tested conventional method including Xpert TB/RIF assay, and new diagnostic technique using homobifunctionalImidoesters compounds.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients who are suspected with pulmonary tuberculosis, tuberculosis meningitis, tuberculosis peritonitis, tuberculosis pleurisy

Exclusion criteria

* Under 18 years

Design outcomes

Primary

Measure	Time frame	Description
The effectiveness of new diagnostic technique	An average of 2 year	sensitivity and specificity of new test

Countries

South Korea

Contacts

Primary ContactSeiwon Lee

iseiwon@gmail.com82-10-3010-3990

Outcome results